This weekly report provides a current epidemiological update on the intensity and severity of respiratory activity in Manitoba including laboratory confirmed activity of both COVID-19 and seasonal influenza. Surveillance data include syndromic indicators, laboratory testing, associated hospitalization and mortality, and outbreaks. Updates around immunization coverage in COVID-19 and seasonal influenza are also included.
Data are reported with a one-week delay for increased data accuracy, completeness and reliability. More analyses continue to be conducted and will be added to this report as available. It is published online at approximately 3:00pm every Friday.
Data extracted up to 1:00 am on August 29, 2024
Next reporting date: September 6, 2024
|
|
|||||||||||||
|
||||||||||||||
|
||||||||||||||
|
|
|||||||||||||
|
|
|||||||||||||
|
|
|
||||||||||||
Important Notes
|
Figure 1. Weekly Cases of COVID-19 by Season, Manitoba, 2021 – 2025 (June through June)
Figure 2. Sex and Age Distribution of COVID-19 Cases, Manitoba, June 30, 2024 – August 24, 2024
Figure 3. Cases of COVID-19 by Health Region and Public Health Report Date, Manitoba, June 30, 2024 – August 24, 2024
Figure 4. Average Daily Testing Volume and Positivity (%) for COVID-19 by Week of Specimen Receiving Date, Manitoba, June 30, 2024 – August 24, 2024
Table 1. Fall COVID-19 Campaign Coverage (at least 1 dose) and Coverage in the Last Six Months by Age Group
Age group | Number Vaccinated | %Coverage | Number Vaccinated | %Coverage | Number Vaccinated | %Coverage |
---|---|---|---|---|---|---|
00-04 | 5023 | 6.0% | 4196 | 5.0% | 532 | 0.6% |
05-17 | 23493 | 10.1% | 15534 | 6.7% | 592 | 0.3% |
18-49 | 77938 | 12.8% | 53880 | 8.9% | 1777 | 0.3% |
50-64 | 74266 | 28.6% | 61570 | 23.7% | 2357 | 0.9% |
65+ | 151039 | 62.1% | 139899 | 57.5% | 16937 | 7.0% |
All | 357089 | 25.0% | 290977 | 20.4% | 22364 | 1.6% |
Figure 5. Weekly Cases of Influenza by Season, Manitoba, 2020 – 2025 (June through June)
Figure 6. Average Daily Testing Volume and Positivity (%) for Influenza by Week of Specimen Receiving Date, Manitoba, June 30, 2024 – August 24, 2024
Figure 7. Number of Positive Respiratory Virus Tests by Week of Specimen Receiving Date, Manitoba, June 30, 2024 – August 24, 2024
Note. Other respiratory viruses include adenovirus, enterovirus/rhinovirus, human coronavirus (seasonal), human metapneumovirus and human parainfluenza virus.
BackFigure 8. Weekly Respiratory Outbreaks, Manitoba, 2021 – August 24, 2024
Table 2. Coverage of Influenza Vaccinations, Manitoba
Age group | Number Vaccinated | %Coverage | Number Vaccinated | %Coverage |
---|---|---|---|---|
0-4 | 17511 | 20.9% | 14663 | 17.5% |
5-17 | 37354 | 15.7% | 32030 | 13.4% |
18-49 | 95923 | 15.4% | 90177 | 14.5% |
50-64 | 83205 | 32.3% | 78525 | 30.4% |
65+ | 146408 | 58.9% | 148766 | 59.9% |
All | 386652 | 26.7% | 368896 | 25.4% |
Note. Actual number of people vaccinated between September 1 and August 24, 2024 may be higher due to delays in reporting doses administered.
Figure 9. Weekly FluWatchers Participants and Percentage Reporting Fever and Cough, Manitoba, 2020 – August 24, 2024
Figure 10. Weekly Percentage of ILI Related Visits to Sentinel Physicians, Manitoba, 2018 – August 24, 2024
Note. Due to small numbers the rates should be interpreted with caution.
Figure 11. Weekly Units of Antiviral Dispensed from Pharmacies, Manitoba, 2020 – August 24, 2024
Figure 12. Weekly Respiratory Visits to Emergency Department, Manitoba, 2017 – August 24, 2024